Copyright: ©Author(s) 2026.
World J Hepatol. Apr 27, 2026; 18(4): 115060
Published online Apr 27, 2026. doi: 10.4254/wjh.v18.i4.115060
Published online Apr 27, 2026. doi: 10.4254/wjh.v18.i4.115060
Table 4 Episodes of non-variceal bleeding, n (%)
| 2012 | 2019 | |
| Patients admitted with a significant non-variceal haemorrhage | 23 | 51 |
| Etiology of liver disease | ||
| Alcohol | 9 (39.1) | 29 (56.9) |
| Autoimmune | 1 (4.3) | 2 (3.9) |
| HBV | 2 (8.7) | 1 (2) |
| HCV | 6 (26.1) | 7 (13.7) |
| NASH | 2 (8.7) | 10 (19.6) |
| Other | 3 (13) | 2 (3.9) |
| Antiplatelet or anticoagulation therapy | ||
| Yes | 1 (4.3) | 14 (27.5) |
| No | 22 (95.7) | 37 (72.5) |
| Patients taking antiplatelet/anticoagulant therapy by etiology of liver disease | ||
| Alcohol | 0 | 4 |
| Autoimmune | 0 | 0 |
| HBV | 0 | 1 |
| HCV | 0 | 3 |
| NASH | 1 | 6 |
| Other | 0 | 0 |
| Cause of non-variceal bleeding (number of episodes) | ||
| GAVE/portal hypertensive gastropathy | 24 | 32 |
| Peptic ulcer | 5 | 11 |
| Other upper gastrointestinal pathology | 3 | 7 |
| Non-upper gastrointestinal bleed | 3 | 23 |
- Citation: Terbah R, Zhao C, Greeve T, Cannan E, Wong D, Testro A, Majumdar A, Sinclair M. Shifting cirrhosis phenotype with changes in liver disease etiology in an Australian tertiary hospital. World J Hepatol 2026; 18(4): 115060
- URL: https://www.wjgnet.com/1948-5182/full/v18/i4/115060.htm
- DOI: https://dx.doi.org/10.4254/wjh.v18.i4.115060